Journal of Internal Medicine Concepts & Practice ›› 2023, Vol. 18 ›› Issue (06): 383-387.doi: 10.16138/j.1673-6087.2023.06.002
• Original article • Previous Articles Next Articles
ZHAO Yajie, HE Qing, XU Zhihong()
Received:
2022-11-01
Online:
2023-12-18
Published:
2024-03-18
CLC Number:
ZHAO Yajie, HE Qing, XU Zhihong. Impact of sarcopenia on quality of life and mobility in elderly patients with chronic obstructive pulmonary disease[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(06): 383-387.
指标 | 非肌少症组(n=60) | 肌少症组(n=32) | t/χ2 | P |
---|---|---|---|---|
年龄(岁) | 77.1±5.2 | 82.6±7.3 | 2.567 | 0.026 |
男性[n(%)] | 49(81.7) | 28(87.5) | 0.520 | 0.471 |
白细胞计数(×109/L) | 6.2±1.6 | 6.0±1.4 | 0.609 | 0.544 |
血红蛋白(g/L) | 126.9±14.5 | 114.6±13.9 | 4.087 | 0.002 |
白蛋白(g/L) | 38.7±3.4 | 34.6±3.5 | 5.470 | 0.009 |
尿酸(μmol/L) | 332.6±51.0 | 334.2±51.1 | 0.053 | 0.948 |
肌酐(μmol/L) | 76.4±10.9 | 80.9±11.5 | 0.860 | 0.552 |
总胆固醇(mmol/L) | 4.1±0.9 | 4.3±1.1 | 1.905 | 0.058 |
甘油三酯(mmol/L) | 1.4±0.7 | 1.6±0.9 | 1.825 | 0.069 |
血清钾(mmol/L) | 3.7±0.5 | 3.8±0.4 | 0.657 | 0.624 |
血清钠(mmol/L) | 136.2±6.9 | 137.4±5.4 | 0.442 | 0.644 |
血清钙(mmol/L) | 2.1±0.1 | 2.2±0.1 | 1.761 | 0.081 |
FEV1% | 58.8±21.9 | 52.7±17.5 | 1.840 | 0.680 |
FVC% | 83.4±21.2 | 81.9±18.6 | 0.446 | 0.656 |
FEV1/FVC(%) | 54.8±11.1 | 50.4±10.2 | 2.465 | 0.150 |
GOLD 1级[n(%)] | 4(6.7) | 1(3.1) | 0.517 | 0.772 |
GOLD 2级[n(%)] | 54(90) | 30(93.8) | ||
GOLD 3级[n(%)] | 2(3.3) | 1(3.1) | ||
LABA/LAMA[n(%)] | 10(16.7) | 3(9.4) | 1.571 | 0.456 |
ICS/LABA[n(%)] | 46(76.7) | 28(87.5) | ||
ICS/LABA/LAMA[n(%)] | 4(6.7) | 1(3.1) | ||
BMI(kg/m2) | 25.4±3.0 | 20.2±2.2 | 8.853 | 0.006 |
ASM(kg) | 23.4±2.5 | 18.7±2.5 | 14.846 | 0.005 |
SMI(kg/m2) | 8.0±0.6 | 5.6±0.5 | 17.868 | 0.004 |
握力(kg) | 29.7±3.0 | 21.0±5.4 | 9.638 | 0.006 |
mMRC评分(分) | 0.9±0.7 | 1.4±1.0 | 8.729 | 0.013 |
CAT评分(分) | 8.4±4.3 | 11.7±4.4 | 5.131 | 0.008 |
6 m步速(m/s) | 1.1±0.2 | 0.7±0.2 | 4.286 | 0.006 |
指标 | FEV1% | FVC% | FEV1/FVC | mMRC | CAT | 6 m步速 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
r | P | r | P | r | P | r | P | r | P | r | P | ||||||
非肌少症组 | |||||||||||||||||
BMI | 0.376 | 0.031 | 0.894 | 0.388 | 0.056 | 0.716 | -0.340 | 0.032 | -0.354 | 0.043 | 0.436 | 0.015 | |||||
SMI | 0.365 | 0.037 | 0.075 | 0.629 | 0.003 | 0.894 | -0.262 | 0.023 | -0.367 | 0.036 | 0.392 | 0.024 | |||||
握力 | 0.094 | 0.541 | 0.056 | 0.716 | 0.293 | 0.110 | -0.327 | 0.064 | -0.316 | 0.073 | 0.319 | 0.071 | |||||
肌少症组 | |||||||||||||||||
BMI | 0.257 | 0.026 | 0.619 | 0.071 | 0.225 | 0.162 | -0.293 | 0.010 | -0.306 | 0.004 | 0.93 | 0.001 | |||||
SMI | 0.696 | 0.004 | 0.193 | 0.199 | 0.760 | 0.002 | -0.645 | 0.002 | -0.594 | 0.003 | 0.86 | 0.002 | |||||
握力 | 0.343 | 0.020 | 0.541 | 0.438 | 0.359 | 0.040 | -0.524 | 0.003 | -0.571 | 0.018 | 0.329 | 0.062 |
因素 | mMRC | CAT | 6 m步速 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
OR | 95%CI | P | OR | 95%CI | P | OR | 95%CI | P | |||
年龄 | 0.973 | 0.869,1.092 | 0.726 | 0.978 | 0.870,1.102 | 0.691 | 0.914 | 0.831,1.062 | 0.738 | ||
血红蛋白 | 1.117 | 0.512,2.438 | 0.783 | 0.991 | 0.915,1.097 | 0.527 | 1.015 | 0.485,1.629 | 0.503 | ||
白蛋白 | 1.146 | 0.899,1.303 | 0.095 | 1.133 | 0.882,1.324 | 0.101 | 1.193 | 0.953,1.997 | 0.072 | ||
FEV1 | 0.971 | 0.862,1.086 | 0.874 | 0.984 | 0.857,1.121 | 0.933 | 1.077 | 0.857,1.592 | 0.394 | ||
FVC% | 0.936 | 0.829,1.341 | 0.939 | 0.949 | 0.856,1.381 | 0.273 | 1.136 | 0.931,2.018 | 0.483 | ||
FEV1/FVC | 0.201 | 0.006,4.329 | 0.302 | 0.198 | 0.007,4.297 | 0.192 | 1.094 | 0.873,1.615 | 0.442 | ||
BMI | 0.316 | 0.061,1.172 | 0.109 | 0.526 | 0.091,1.212 | 0.825 | 3.875 | 1.973,5.148 | 0.017 | ||
握力 | 1.501 | 0.919,2.433 | 0.121 | 1.442 | 0.927,2.252 | 0.098 | 1.069 | 0.775,1.865 | 0.089 | ||
SMI | 0.169 | 0.066,0.479 | 0.002 | 0.173 | 0.059,0.437 | 0.002 | 4.017 | 2.174,5.992 | 0.011 |
[1] |
Singh D. Pharmacological treatment of stable chronic obstructive pulmonary disease[J]. Respirology, 2021, 26(7):643-651.
doi: 10.1111/resp.14046 pmid: 33829619 |
[2] |
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing. 2019, 48(1):16-31.
doi: 10.1093/ageing/afy169 pmid: 30312372 |
[3] |
Kyomoto Y, Asai K, Yamada K, et al. Handgrip strength measurement in patients with chronic obstructive pulmonary disease[J]. Respir Investig, 2019, 57(5): 499-505.
doi: S2212-5345(18)30302-2 pmid: 31085119 |
[4] |
Wang X, Liang Q, Li Z, et al. Body composition and COPD[J]. Int J Chron Obstruct Pulmon Dis, 2023, 18: 79-97.
doi: 10.2147/COPD.S394907 URL |
[5] |
Jacobsen PA, van ’t Hul AJ, Djamin RS, et al. Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employment[J]. Respir Res, 2021, 22(1): 147.
doi: 10.1186/s12931-021-01736-6 |
[6] | 时延伟, 张二明, 郭伟安, 等. CAT评分对慢性阻塞性肺疾病患者病情及疗效的评估价值[J]. 基层医学论坛, 2021, 25(2): 152-155. |
[7] |
Bartziokas K, Papaporfyriou A, Hillas G, et al. Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations: strengths and concerns for future needs[J]. Postgrad Med, 2023, 135(4): 327-333.
doi: 10.1080/00325481.2022.2135893 URL |
[8] |
Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307.
doi: 10.1016/j.jamda.2019.12.012 URL |
[9] |
Tournadre A, Vial G, Capel F, et al. Sarcopenia[J]. Joint Bone Spine, 2019, 86(3): 309-314.
doi: S1297-319X(18)30189-1 pmid: 30098424 |
[10] | 胡丽, 赵旭, 黄小明. 老年慢性阻塞性肺疾病患者营养状况及其与少肌症的相关性[J]. 国际老年医学杂志, 2021, 42(1): 31-35. |
[11] |
Trajanoska K, Schoufour JD, Darweesh SK, et al. Sarcopenia and its clinical correlates in the general population[J]. J Bone Miner Res, 2018, 33(7): 1209-1218.
doi: 10.1002/jbmr.3416 pmid: 29502340 |
[12] |
Sepúlveda-Loyola W, Osadnik C, Phu S, et al. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD[J]. J Cachexia Sarcopenia Muscle, 2020, 11(5): 1164-1176.
doi: 10.1002/jcsm.v11.5 URL |
[13] | Benz E, Trajanoska K, Lahousse L, et al. Sarcopenia in COPD: a systematic review and meta-analysis[J]. Eur Respir Rev, 2019, 28(154): 190049. |
[14] | 丁怿虹, 施劲东, 刘勤, 等. 慢性阻塞性肺疾病患者体重指数和骨密度骨骼肌功能相关性研究[J]. 中国实用内科杂志, 2016, 36(8): 675-679. |
[15] |
Chen X, Wang Q, Hu Y, et al. A Nomogram for predicting severe exacerbations in stable COPD patients[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15: 379-388.
doi: 10.2147/COPD URL |
[16] |
Park HJ, Cho JH, Kim HJ, et al. The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality[J]. J Intern Med, 2019, 286(5): 573-582.
doi: 10.1111/joim.12949 pmid: 31215064 |
[17] |
McDonald MN, Wouters EFM, Rutten E, et al. It’s more than low BMI: prevalence of cachexia and associated mortality in COPD[J]. Respir Res, 2019, 20(1): 100.
doi: 10.1186/s12931-019-1073-3 |
[18] |
Lim JU, Lee JH, Kim JS, et al. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12: 2465-2475.
doi: 10.2147/COPD URL |
[19] |
Guo Y, Zhang T, Wang Z, et al. Body mass index and mortality in chronic obstructive pulmonary disease[J]. Medicine (Baltimore), 2016, 95(28): e4225.
doi: 10.1097/MD.0000000000004225 URL |
[20] | 石劢, 吕春健, 赵凤梅, 等. 稳定期慢阻肺患者合并肌少症时对其生活质量的影响[J]. 中国食物营养, 2020, 26(11): 69-73. |
[21] |
Kaluźniak-Szymanowska A, Krzymińska-Siemaszko R, Deskur-śmielecka E, et al. Malnutrition, sarcopenia, and malnutrition-sarcopenia syndrome in older adults with COPD[J]. Nutrients, 2021, 14(1): 44.
doi: 10.3390/nu14010044 URL |
[22] | Benz E, Wijnant SRA, Trajanoska K, et al. Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma[J]. ERJ Open Res. 2022, 8(1): 00628-2021. |
[23] |
Lena A, Anker MS, Springer J. Muscle wasting and sarcopenia in heart failure-the current state of science[J]. Int J Mol Sci, 2020, 21(18): 6549.
doi: 10.3390/ijms21186549 URL |
[1] | ZHANG Yin, SHEN Honghua, XU Yiming, REN Lei, LI jun, WU Shunjun, LING Xiaonan. Effect of sarcopenia combined with abdominal obesity on muscle strength and physical function in hospitalized elderly [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(02): 76-82. |
[2] | LI Feika, YANG Wenli, JIANG Qianwen, FANG Fang, BAI Tingting, XU Gang, WU Fang, HE Qing. Development of preliminary scales for elderly sarcopenia based on Delphi method [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 238-242. |
[3] | QIU Liwen, XU Yiming, ZHANG Yin, SHEN Honghua, CHEN Shen. Evaluate therapeutic efficacy of resistance training and aerobic training for gerontal patients with chronic obstructive pulmonary disease [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 78-83. |
[4] | . [J]. Journal of Internal Medicine Concepts & Practice, 2020, 15(01): 31-37. |
[5] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(06): 337-341. |
[6] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(04): 225-229. |
[7] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(04): 239-243. |
[8] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(03): 172-177. |
[9] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(03): 154-160. |
[10] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(01): 43-47. |
[11] | . [J]. Journal of Internal Medicine Concepts & Practice, 2018, 13(06): 368-374. |
[12] | . [J]. Journal of Internal Medicine Concepts & Practice, 2018, 13(01): 46-52. |
[13] | . [J]. Journal of Internal Medicine Concepts & Practice, 2015, 10(06): 407-412. |
[14] | . [J]. Journal of Internal Medicine Concepts & Practice, 2015, 10(03): 172-176. |
[15] | . [J]. Journal of Internal Medicine Concepts & Practice, 2014, 9(06): 407-410. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||